LENSAR Inc. has unveiled its latest corporate presentation, highlighting its role as a leading innovator in the laser cataract surgery market. The company emphasizes its ALLY Robotic Cataract Laser System, which integrates robotic intelligence with surgeon expertise to enhance surgical outcomes. The presentation notes that LENSAR holds approximately 21% of the global laser-assisted cataract surgery market share as of Q2 2025. The ALLY system is designed to optimize treatment through advanced imaging and AI, offering significant time savings and improved efficiencies. The presentation also discusses the market potential for cataract procedures, with an estimated 32 million surgeries worldwide in 2025. LENSAR's recent regulatory approvals in the EU and Southeast Asia are expected to broaden its market opportunities. You can access the full presentation through the link below.